user

PAI-1 and uPA as Biomarkers in Breast Cancer: From Pilot Studies to Recommendation for Clinical Use

被引：0
|
作者：
Duffy, M. J. [1 ]
机构：
[1] St Vincents Univ Hosp, Dept Pathol & Lab Med, Dublin 4, Ireland
来源：
TUMOR BIOLOGY | 2008年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [31] Study on the prognostic impact of uPA and PAI-1 for nodal negative invasive breast cancer
    Streckert, I.
    Bonatz, G.
    Kucharski, K.
    Marek, W.
    Streckert, H.-J.
    Philippou, S.
    PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (05) : 303 - 304
  • [32] Clinical significance and future of the prognostic factors uPA and PAI-1 for nodal-negative invasive breast cancer
    Streckert, I
    Bonatz, G.
    Kucharski, K.
    Marek, W.
    Streckert, H. J.
    Phillipou, S.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 (03) : 304 - 304
  • [33] uPA/PAI-1, Oncotype DX™, MammaPrintA® Prognosis and predictive values for clinical utility in breast cancer management
    Luporsi, E.
    Bellocq, J. P.
    Barriere, J.
    Bonastre, J.
    Chetritt, J.
    Le Corroller, A. G.
    de Cremoux, P.
    Fina, F.
    Gauchez, A. S.
    Lamy, P. J.
    Martin, P. M.
    Mazouni, C.
    Peyrat, J. P.
    Romieu, G.
    Verdoni, L.
    Mazeau-Woynar, V.
    Kassab-Chahmi, D.
    ONCOLOGIE, 2014, 16 (04) : 196 - 206
  • [34] Prognostic value of UPA, PAI-1, and PAI-2 mRNA expression in primary breast cancer.
    Spyratos, F
    Bouchet, C
    Tozlu, S
    Labroquère, M
    Vignaud, S
    Becette, V
    Lidereau, R
    Bièche, I
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 262 - 262
  • [35] The tumor marker impact of PAI-1 and UPA in colorectal cancer
    Herszenyi, L
    Farinati, F
    Gabor, I
    De Paoli, M
    Roveroni, G
    Plebani, M
    Naccarato, R
    Tulassay, Z
    GASTROENTEROLOGY, 2002, 122 (04) : A486 - A486
  • [36] Micromethod for determination of uPA and PAI-1 from preoperative core-needle biopsies in breast cancer.
    Abraha, RS
    Thomssen, C
    Harbeck, N
    Mueller, V
    Baack, K
    Schmitt, M
    Jaenicke, F
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S144 - S144
  • [37] Role of uPA and PAI-1 mRNA expression as prognostic factors in molecular subtypes of breast cancer
    Witzel, I.
    Milde-Langosch, K.
    Schmidt, M.
    Karn, T.
    Rody, A.
    Wirtz, R.
    Jaenicke, F.
    Mueller, V.
    CANCER RESEARCH, 2013, 73
  • [38] uPA and PAI-1 in breast cancer: Review of their clinical utility and current validation in the prospective NNBC-3 trial
    Annecke, K.
    Schmitt, M.
    Euler, U.
    Zerm, M.
    Paepke, D.
    Paepke, S.
    von Minckwitz, G.
    Thomssen, C.
    Harbeck, N.
    ADVANCES IN CLINICAL CHEMISTRY, VOL 45, 2008, 45 : 31 - 45
  • [39] Characteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1
    Mengele, Karin
    Napieralski, Rudolf
    Magdolen, Viktor
    Reuning, Ute
    Gkazepis, Apostolos
    Sweep, Fred
    Bruenner, Nils
    Foekens, John
    Harbeck, Nadia
    Schmittt, Manfred
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2010, 10 (07) : 947 - 962
  • [40] EndoPredict versus uPA/PAI-1 in breast cancer: Comparison of markers and association with clinicopathological parameters
    Jakubowicz, Elzbieta
    Martin, Benedikt
    Hoffmann, Reinhard
    Kroencke, Thomas
    Jung, Thomas
    Steierl, Roman
    Steinfeld, Dieter
    Schenkirsch, Gerhard
    Kriegsmann, Joerg
    Maerkl, Bruno
    BREAST JOURNAL, 2019, 25 (03): : 450 - 454
12345